Abstract
Since lymph node metastases are one of the most important prognostic factors, treatment of the neck is challenging. In clinically N0 neck, (super)selective neck dissection is indicated, whereas a more extensive neck dissection with preservation of important structures is performed in N2-N3 disease. Adjuvant treatment consists of radiotherapy with or without chemotherapy in patients with an intermediate or high risk of recurrence in the neck. Primary radiotherapy alone is effective in non-bulky disease. In more extensive neck disease, a combination of radiotherapy and chemotherapy with or without planned neck dissection is indicated. Advances in imaging and treatment as well as risk assessment have further modified the paradigm of planned neck dissection. Primary chemoradiation is effective for sterilising occult disease, and, therefore, post-treatment (super)selective neck dissection seems to be sufficient.
Original language | English |
---|---|
Title of host publication | Head and Neck Cancer |
Subtitle of host publication | Multimodality Management |
Editors | Jacques Bernier |
Publisher | Springer International Publishing |
Pages | 591-606 |
Number of pages | 16 |
Edition | 2 |
ISBN (Electronic) | 9783319276014 |
ISBN (Print) | 9783319275994 |
DOIs | |
Publication status | Published - 1 Jan 2016 |
Keywords
- Chemoradiation
- Lymph node metastases
- Neck dissection
- Radiotherapy
- Salvage surgery